UCLA Partners with Singapore, Boeing-Backed Equatic for World's Largest Ocean-Based CO2 Removal Plant

In a groundbreaking development, UCLA, together with Boeing Co.-backed startup Equatic, Singapore’s PUB, and the National Research Foundation, is set to construct a $20 million plant aimed at removing carbon dioxide from the atmosphere and producing hydrogen. This initiative not only marks a significant step towards combating climate change but also showcases UCLA’s multifaceted contributions across various sectors, from healthcare innovations to advancements in mental health and education.

Revolutionizing Carbon Management

The collaboration brings to life the world’s largest ocean-based CO2 removal plant in Tuas, Singapore. With an ambitious goal to remove 10 tonnes of CO2 daily while generating 300 kilograms of carbon-negative hydrogen, this project stands as a testament to the potential of global partnerships in addressing environmental challenges. The plant, named Equatic 1, leverages seawater, air, rock, and renewable electricity, embodying a pioneering approach to carbon management and hydrogen production.

Expanding Frontiers in Healthcare and Mental Health

Parallel to its environmental endeavors, UCLA continues to make strides in healthcare and mental health. UCLA Hospital System CEO Johnese Spisso highlighted the cautious yet optimistic adoption of AI technologies in healthcare, emphasizing the importance of safety. Meanwhile, Dr. Helen Lavretsky’s study from UCLA Health revealed yoga’s benefits on brain health and its potential in reducing Alzheimer’s risk factors among older women, further underscoring UCLA’s comprehensive research capabilities.

Educational and Social Contributions

UCLA’s impact extends into the realms of education and social awareness. A recent study shed light on the insufficiencies of Black history education in American schools, while the Williams Institute at UCLA Law offered new insights into the transgender and intersex populations in the U.S. Additionally, the David Geffen School of Medicine at UCLA’s merit-based scholarships, supported by $146 million in donations, highlight the institution’s commitment to fostering education and research excellence.

As the Tuas plant moves towards its construction phase in March 2024, the initiative not only represents a significant leap towards achieving net zero emissions by 2045 but also exemplifies UCLA’s dedication to pioneering sustainable solutions, advancing healthcare, and championing social progress.